Finola E. Moore

1.3k total citations
18 papers, 987 citations indexed

About

Finola E. Moore is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Finola E. Moore has authored 18 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cell Biology and 7 papers in Immunology. Recurrent topics in Finola E. Moore's work include Zebrafish Biomedical Research Applications (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Finola E. Moore is often cited by papers focused on Zebrafish Biomedical Research Applications (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Finola E. Moore collaborates with scholars based in United States, Belgium and Canada. Finola E. Moore's co-authors include David M. Langenau, Richard I. Morimoto, Heather R. Brignull, Jessica S. Blackburn, Sarah Martinez, Riadh Lobbardi, Qin Tang, John C. Moore, James T. Becker and Arthur F. Stucchi and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Neuroscience and The Journal of Cell Biology.

In The Last Decade

Finola E. Moore

17 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finola E. Moore United States 12 583 327 186 121 118 18 987
Hanneke Okkenhaug United Kingdom 18 698 1.2× 255 0.8× 124 0.7× 44 0.4× 103 0.9× 30 1.1k
Sanjoy K. Khan United States 14 391 0.7× 240 0.7× 89 0.5× 69 0.6× 90 0.8× 16 925
Shaosong Yang United States 12 745 1.3× 174 0.5× 97 0.5× 120 1.0× 56 0.5× 13 1.1k
Yosuke Horikoshi Japan 15 727 1.2× 581 1.8× 73 0.4× 59 0.5× 118 1.0× 30 1.2k
Michael C. Kacergis United States 8 616 1.1× 235 0.7× 74 0.4× 102 0.8× 60 0.5× 8 891
Roberta Tufi United Kingdom 15 592 1.0× 314 1.0× 298 1.6× 42 0.3× 124 1.1× 17 1.2k
Jose M. Orozco United States 7 965 1.7× 269 0.8× 93 0.5× 88 0.7× 47 0.4× 8 1.3k
Gabriela Estepa United States 7 482 0.8× 112 0.3× 198 1.1× 145 1.2× 83 0.7× 8 940
Aida M. Mamarbachi Canada 18 683 1.2× 262 0.8× 119 0.6× 38 0.3× 229 1.9× 25 1.1k

Countries citing papers authored by Finola E. Moore

Since Specialization
Citations

This map shows the geographic impact of Finola E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finola E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finola E. Moore more than expected).

Fields of papers citing papers by Finola E. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finola E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finola E. Moore. The network helps show where Finola E. Moore may publish in the future.

Co-authorship network of co-authors of Finola E. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Finola E. Moore. A scholar is included among the top collaborators of Finola E. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finola E. Moore. Finola E. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hamza, Bashar, Ángela Núñez, Henry Gómez, et al.. (2023). Abstract 2904: CAT-179, an allogeneic NK cell product expressing HER2-CAR, IL-15 and TGFβ dominant negative receptor, durably regresses HER2-expressing xenograft tumors in mice. Cancer Research. 83(7_Supplement). 2904–2904. 1 indexed citations
2.
Richardson, Celeste, Finola E. Moore, Luke Barron, et al.. (2022). Abstract 555: Allogeneic Natural Killer cells engineered to express HER2 CAR, Interleukin 15 and TGF beta dominant negative receptor effectively control HER2+ tumors. Cancer Research. 82(12_Supplement). 555–555. 1 indexed citations
3.
Loontiens, Siebe, Inge Van de Walle, Finola E. Moore, et al.. (2020). PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation. Frontiers in Cell and Developmental Biology. 8. 599472–599472. 5 indexed citations
4.
Lee, Thomas, et al.. (2019). 1743-P: Engineering Erythrocytes with the SQZ Cell Therapy Platform to Enhance Immunotolerance. Diabetes. 68(Supplement_1). 1 indexed citations
5.
Ignatius, Myron S., Madeline N. Hayes, Finola E. Moore, et al.. (2018). tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. eLife. 7. 44 indexed citations
6.
Painter, Corrie, Finola E. Moore, Riadh Lobbardi, et al.. (2017). Identification and characterization of T reg–like cells in zebrafish. The Journal of Experimental Medicine. 214(12). 3519–3530. 53 indexed citations
7.
Moore, John C., Qin Tang, Finola E. Moore, et al.. (2016). Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish. The Journal of Experimental Medicine. 213(12). 2575–2589. 56 indexed citations
8.
Moore, Finola E., Elaine G. Garcia, Riadh Lobbardi, et al.. (2016). Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish. The Journal of Experimental Medicine. 213(6). 979–992. 55 indexed citations
9.
Moore, Finola E., Elaine G. Garcia, Riadh Lobbardi, et al.. (2016). Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish. The Journal of Cell Biology. 213(3). 2133OIA95–2133OIA95.
10.
Tang, Qin, Nouran S. Abdelfattah, Jessica S. Blackburn, et al.. (2014). Optimized cell transplantation using adult rag2 mutant zebrafish. Nature Methods. 11(8). 821–824. 115 indexed citations
11.
Blackburn, Jessica S., Sali Liu, Kimberly P. Dobrinski, et al.. (2014). Clonal Evolution Enhances Leukemia-Propagating Cell Frequency in T Cell Acute Lymphoblastic Leukemia through Akt/mTORC1 Pathway Activation. Cancer Cell. 25(3). 366–378. 87 indexed citations
12.
Moore, Finola E., Deepak Reyon, Jeffry D. Sander, et al.. (2012). Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs). PLoS ONE. 7(5). e37877–e37877. 128 indexed citations
13.
Moore, Finola E. & David M. Langenau. (2012). Through the Looking Glass: Visualizing Leukemia Growth, Migration, and Engraftment Using Fluorescent Transgenic Zebrafish. Advances in Hematology. 2012. 1–8. 9 indexed citations
14.
Moore, Finola E., Evan C. Osmundson, Jennifer E. Koblinski, et al.. (2010). The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation. Cell Division. 5(1). 22–22. 19 indexed citations
15.
Osmundson, Evan C., Dipankar Ray, Finola E. Moore, et al.. (2008). The HECT E3 ligase Smurf2 is required for Mad2-dependent spindle assembly checkpoint. The Journal of Cell Biology. 183(2). 267–277. 52 indexed citations
16.
Krieser, Ronald J., Finola E. Moore, Brett J. Pellock, et al.. (2007). TheDrosophilahomolog of the putative phosphatidylserine receptor functions to inhibit apoptosis. Development. 134(13). 2407–2414. 30 indexed citations
17.
Brignull, Heather R., et al.. (2006). Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-Specific Aggregation in a Pan-NeuronalCaenorhabditis elegansModel. Journal of Neuroscience. 26(29). 7597–7606. 177 indexed citations
18.
Stucchi, Arthur F., Scott Shofer, Susan E. Leeman, et al.. (2000). NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 279(6). G1298–G1306. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026